web analytics

Condoms that Can Kill HIV Get Approved in Australia

condoms

Image credit: trec_lit via Flickr.

With content of an antiviral compound, VivaGel, if used for as the condom coating, is capable of cutting down the risk of being exposed to viruses which can cause sexually transmitted infections.

In the lab, such antimicrobial agent called astodrimer sodium could inactivate more than 99.9 percent of HIV (human immunodeficiency virus), HPV (human papilloma virus) as well as HSV (herpes simplex virus).

Recently Starpharma, the manufacturer of VivaGel, which is based at Melbourne, Australia, got the regulatory approval from the Australian Therapeutic Goods Administration (TGA), the similar authority like the Food and Drug Administration in the U.S. With such permission, the company is allowed to sell its products in the market, like a CE mark in Europe.

After this official, final step in which the VivaGel was listed on the Australian Register of Therapeutic Goods, Starpharma and Ansell, its marketing partner are planning to sell  the VivaGel-coated condoms branded as LifeStyles Dual Protect soon. Okamoto Industries, the Japanese company will be responsible for the marketing of such condom in Japan, because VivaGel has been approved earlier this year.

According to Jackie Fairley from the company of Starpharma, though it is not 100 percent effective for condoms to prevent either pregnancy or sexually transmitted infections, you should do anything possible to decrease the number of virus particles by the means of inactivating them. The substance like VivaGel would be a useful solution to reduction of the overall viral load.

As present, VivaGel is under test in the U.S. for treating the bacterial vaginosis, which is regarded as an imbalance in the normal vaginal microflora.

Source: The Wall Street Journal

You May Also Like:

A New Test Method Can Diagnose Asthma Using a Single Drop of Blood
Incredible X-ray GIFs Illustrate Joints in Motion
Novel Drug Delivery Capsule May Substitute Injections
Scientists Identify Vaccine-Resistant Polio Strain